AstraZeneca PLC (US) (NYSE:AZN) is on the cusp of unlocking a new growth engine in lung cancer treatment. On September 29, ...

Sept 29 (Reuters) - HUTCHMED (China) said on Tuesday that Anglo-Swedish drugmaker AstraZeneca had applied to the US Food and Drug Administration for approval of the ORPATHYS-TAGRISSO combination to ...

AstraZeneca stock edged lower despite the US FDA granting accelerated approval for the company’s new breast cancer pill ...

The US Food and Drug Administration (FDA) has granted accelerated approval to AstraZeneca's Etcamah (camizestrant), used with a cyclin-dependent kinase (CDK) 4/6 inhibitor (abemaciclib, palbociclib or ...

The US Food and Drug Administration (FDA) said on Friday it granted accelerated approval to AstraZeneca Plc’s breast cancer pill, expanding treatment options for adult patients with advanced breast ...

Citi has maintained its 'buy' rating on AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) with a target price of £186, arguing that ...

(Alliance News) - AstraZeneca PLC on Tuesday said its biologics licence application for tozorakimab in the US was accepted under priority review. The Cambridge, England-based pharmaceutical company ...

AstraZeneca PLC and its partner Daiichi Sankyo Co Ltd on Friday announced that their cancer drug Enhertu has been recommended to be approved in the EU for a form of breast cancer. AstraZeneca, the ...

(Alliance News) - AstraZeneca PLC on Monday said its self-administered lupus treatment has been approved in the US. The US Food & Drug Administration has approved the Saphnelo Pen once-weekly ...